| 1 |
histone deacetylase
(5399 times)
|
Neoplasms
(1102 times)
|
TSA (562 times)
VPA (332 times)
SAHA (296 times)
|
1998 Role of the histone deacetylase complex in acute promyelocytic leukaemia.
|
| 2 |
high-dose cytarabine
(37 times)
|
Neoplasms
(19 times)
|
AML (24 times)
CR (14 times)
OS (7 times)
|
1988 Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.
|
| 3 |
histone deacetylase complex
(19 times)
|
Biochemistry
(5 times)
|
TSA (2 times)
AFR1 (1 time)
AZA (1 time)
|
2004 The unfolded protein response represses differentiation through the RPD3-SIN3 histone deacetylase.
|
| 4 |
histone deacetylase inhibitor
(17 times)
|
Neoplasms
(4 times)
|
SAHA (3 times)
VPA (3 times)
TSA (2 times)
|
2008 The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear.
|
| 5 |
high-dose Ara-C
(11 times)
|
Hematology
(7 times)
|
AML (4 times)
CR (4 times)
ALL (2 times)
|
1993 Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.
|
| 6 |
histone deacetylase activity
(8 times)
|
Neoplasms
(2 times)
|
HAT (2 times)
AKI (1 time)
CKD (1 time)
|
2000 Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
|
| 7 |
histone deacetyltransferase
(7 times)
|
Neoplasms
(3 times)
|
HAT (3 times)
TSA (2 times)
5-Aza (1 time)
|
2005 A mechanistic approach to anticancer therapy: targeting the cell cycle with histone deacetylase inhibitors.
|
| 8 |
histone/protein deacetylases
(7 times)
|
Natural Science Disciplines
(2 times)
|
Treg (2 times)
5azaD (1 time)
FOXP3 (1 time)
|
2009 Use of epigenetic modification to induce FOXP3 expression in naive T cells.
|
| 9 |
hydrothermal diamond anvil cell
(7 times)
|
Biophysics
(4 times)
|
4,4'-DBB (1 time)
COD (1 time)
EOS (1 time)
|
2005 [Evidence of discontinuous property of water: study of infrared spectra at high temperature and high pressure].
|
| 10 |
high-dose cytosine arabinoside
(6 times)
|
Neoplasms
(5 times)
|
AHSCT (1 time)
BUN (1 time)
CHOP (1 time)
|
1990 Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study.
|
| 11 |
High-dose acetaminophen
(2 times)
|
Neoplasms
(2 times)
|
NAC (2 times)
AFP (1 time)
MFO (1 time)
|
1996 Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue.
|
| 12 |
high-dose alkylating chemotherapy
(2 times)
|
Breast Neoplasms
(1 time)
|
PPV (2 times)
TNBC (2 times)
aCGH (1 time)
|
2015 Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy.
|
| 13 |
histone-acetylation and -deacetylation
(2 times)
|
Pharmacology
(1 time)
|
AD (1 time)
BMP (1 time)
CYP19A1 (1 time)
|
2015 [EPIGENETIC ENZYMES AS THERAPEUTIC TARGETS FOR TREATING BRAIN DISORDERS].
|
| 14 |
hybrid dilated attention convolutional
(2 times)
|
Biology
(1 time)
|
CA (1 time)
|
2021 Hybrid dilation and attention residual U-Net for medical image segmentation.
|
| 15 |
high dose alcohol consumption
(1 time)
|
Anxiety
(1 time)
|
PTSS (1 time)
|
2017 High dose alcohol consumption predicts less reduction in post-traumatic stress symptoms after a campus mass shooting.
|
| 16 |
high the dose ara-C
(1 time)
|
Neoplasms
(1 time)
|
AML (1 time)
DFS (1 time)
LDAC (1 time)
|
2011 The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine.
|
| 17 |
high-definition attenuation corrected
(1 time)
|
Nuclear Medicine
(1 time)
|
BPLR (1 time)
CT (1 time)
JAFROC (1 time)
|
2020 Detectability of small objects in PET/computed tomography phantom images with Bayesian penalised likelihood reconstruction.
|
| 18 |
high-dose Ara-c group
(1 time)
|
Hematology
(1 time)
|
AML (1 time)
Ara-c (1 time)
LDAC (1 time)
|
2016 Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China.
|
| 19 |
high-dose Ara-C treatment
(1 time)
|
Hematology
(1 time)
|
ALL (1 time)
CRP (1 time)
NHL (1 time)
|
2005 Ara-C fever and infections after high-dose ara-C treatment in pediatric lymphoid malignancies.
|
| 20 |
high-dose ara-C-based chemotherapy
(1 time)
|
Hematology
(1 time)
|
APL (1 time)
ATRA (1 time)
molCR (1 time)
|
2007 Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
|
| 21 |
high-dose arabinosyl cytosine
(1 time)
|
Hematology
(1 time)
|
ALL (1 time)
ANLL (1 time)
CR (1 time)
|
2002 Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
|
| 22 |
high-dose cytarabine chemotherapy
(1 time)
|
Hematologic Diseases
(1 time)
|
allo-SCT (1 time)
CN (1 time)
FLT3-ITD (1 time)
|
2010 Prognostic significance of nucleophosmin mutations and FLT3 internal tandem duplication in adult patients with cytogenetically normal acute myeloid leukemia.
|
| 23 |
high-dose cytarabine consolidation
(1 time)
|
Neoplasms
(1 time)
|
AML (1 time)
CBF (1 time)
CIR (1 time)
|
2008 Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.
|
| 24 |
High-dose cytosine arabinoside or ARA-C
(1 time)
|
Neoplasms
(1 time)
|
---
|
1993 Documentation of neurotoxicity resulting from high-dose cytosine arabinoside.
|
| 25 |
high-dose cytosine-arabinoside/daunorubicin
(1 time)
|
Medicine
(1 time)
|
BMT (1 time)
DAV (1 time)
|
1996 [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
|
| 26 |
histone acetylase and deacetylase
(1 time)
|
Biochemistry
(1 time)
|
ds (1 time)
|
2009 Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase.
|
| 27 |
histone acetyltransferases and deacetylases
(1 time)
|
Biochemistry
(1 time)
|
GFP (1 time)
|
2004 Potent stimulation of gene expression by histone deacetylase inhibitors on transiently transfected DNA.
|
| 28 |
Histone deacetylase inhibitors
(1 time)
|
Molecular Biology
(1 time)
|
TSA (1 time)
|
2015 Effect of HDAC Inhibitors on Corneal Keratocyte Mechanical Phenotypes in 3-D Collagen Matrices.
|
| 29 |
histone deacetylase superfamily
(1 time)
|
Molecular Biology
(1 time)
|
DCHA (1 time)
QM/MM (1 time)
|
2018 Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.
|
| 30 |
histone deacetyltransferase activity
(1 time)
|
Neurology
(1 time)
|
CBP (1 time)
RTS (1 time)
|
2004 Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.
|
| 31 |
histone NAD-dependent deacetylase
(1 time)
|
Medical Informatics
(1 time)
|
HDACs (1 time)
SDP (1 time)
SMC (1 time)
|
2005 Proteins with two SUMO-like domains in chromatin-associated complexes: the RENi (Rad60-Esc2-NIP45) family.
|
| 32 |
hyperdynamic airway collapse
(1 time)
|
Allergy and Immunology
(1 time)
|
TBM (1 time)
|
2013 Tracheomalacia/Tracheobronchomalacia and hyperdynamic airway collapse.
|
| 33 |
microbe-histone deacetylase
(1 time)
|
Environmental Microbiology
(1 time)
|
GPR (1 time)
NFC (1 time)
SCFAs (1 time)
|
2017 Associations among dietary non-fiber carbohydrate, ruminal microbiota and epithelium G-protein-coupled receptor, and histone deacetylase regulations in goats.
|
A Search Service for Abbreviation / Long Form